In the BioHarmony Drug Report Database

"Preview" Icon

Amantadine

Gocovri, Osmolex Er, Symmetrel (amantadine) is a small molecule pharmaceutical. Amantadine was first approved as Gocovri on 1982-01-01. It is used to treat drug-induced akathisia, drug-induced dyskinesia, dystonia, human influenza, and parkinson disease amongst others in the USA. It is known to target glutamate receptor ionotropic, NMDA 2A, glutamate receptor ionotropic, NMDA 2B, glutamate receptor ionotropic, NMDA 2C, and glutamate receptor ionotropic, NMDA 2D. Amantadine hydrochloride’s patents are valid until 2038-08-23 (FDA).

 

Trade Name

 

Gocovri, Osmolex Er, Symmetrel
 

Common Name

 

amantadine
 

ChEMBL ID

 

CHEMBL660
 

Indication

 

drug-induced akathisia, drug-induced dyskinesia, dystonia, human influenza, parkinson disease, secondary parkinson disease
 

Drug Class

 

Antivirals/antiparkinsonians (adamantane derivatives)

Image (chem structure or protein)

Amantadine structure rendering